Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aplindore MR in Restless Legs Syndrome
NCT00834327Phase 2Terminated
- Sponsor
- Neurogen
- Start
- Feb 2009
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aplindore in restless legs syndrome (RLS), sponsored by Neurogen. Started Feb 2009; status: terminated.
02
Drugs
aplindore
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT00834327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00834327.